Human Genome Epidemiology Literature Finder
Records 1 - 10 (of 10 Records) |
Query Trace: Hypersensitivity and CYP2C9[original query] |
---|
Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity. Pharmacogenetics 2000 Nov 10 (8): 705-13. Pirmohamed M, Alfirevic A, Vilar J, Stalford A, Wilkins E G, Sim E, Park B |
Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol. Blood 2002 Jun 99 (11): 4237-9. Hermida José, Zarza José, Alberca Ignacio, Montes Ramón, López María Luz, Molina Eva, Rocha Eduar |
Warfarin dose adjustments based on CYP2C9 genetic polymorphisms. Journal of thrombosis and thrombolysis 2002 Dec 14 (3): 227-32. Linder Mark W, Looney Stephen, Adams Jesse E, Johnson Nancy, Antonino-Green Deborah, Lacefield Nichole, Bukaveckas Bonny L, Valdes Rola |
Implication of novel CYP2C9*57 (p.Asn204His) variant in coumarin hypersensitivity. Thrombosis research 2013 Jun 131 (6): 535-9. Nahar Risha, Dube Divya, Parakh Rajiv, Deb Roumi, Saxena Renu, Singh Tej P, Verma Ishwar |
Genetic determinants of metamizole metabolism modify the risk of developing anaphylaxis. Pharmacogenetics and genomics 2015 Sep 25 (9): 462-4. García-Martín Elena, Esguevillas Gara, Blanca-López Natalia, García-Menaya Jesús, Blanca Miguel, Amo Gemma, Canto Gabriela, Martínez Carmen, Cordobés Concepción, Agúndez José A |
Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model. Current pharmaceutical design 2015 Oct . Urbanová Jana, And?l Michal, Poto?ková Jana, Klíma Josef, Macek Jan, Ptá?ek Pavel, Ma'oška Václav, Kumštý?ová Tereza, Heneberg Pe |
Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions. European journal of clinical pharmacology 2017 Apr . Yampayon Kittika, Sukasem Chonlaphat, Limwongse Chanin, Chinvarun Yotin, Tempark Therdpong, Rerkpattanapipat Ticha, Kijsanayotin Pornpim |
HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians. Clinical pharmacology and therapeutics 2018 Sep . Su Shih-Chi, Chen Chun-Bing, Chang Wan-Chun, Wang Chuang-Wei, Fan Wen-Lang, Lu Lai-Ying, Nakamura Ryosuke, Saito Yoshiro, Ueta Mayumi, Kinoshita Shigeru, Sukasem Chonlaphat, Yampayon Kittika, Kijsanayotin Pornpimol, Nakkam Nontaya, Saksit Niwat, Tassaneeyakul Wichittra, Aihara Michiko, Lin Yu-Jr, Chang Chee-Jen, Wu Tony, Hung Shuen-Iu, Chung Wen-Hu |
HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients. Frontiers in immunology 2021 5 12 661135. Satapornpong Patompong, Pratoomwun Jirawat, Rerknimitr Pawinee, Klaewsongkram Jettanong, Nakkam Nontaya, Rungrotmongkol Thanyada, Konyoung Parinya, Saksit Niwat, Mahakkanukrauh Ajanee, Amornpinyo Warayuwadee, Khunarkornsiri Usanee, Tempark Therdpong, Wantavornprasert Kittipong, Jinda Pimonpan, Koomdee Napatrupron, Jantararoungtong Thawinee, Rerkpattanapipat Ticha, Wang Chuang-Wei, Naisbitt Dean, Tassaneeyakul Wichittra, Ariyachaipanich Manasalak, Roonghiranwat Thapana, Pirmohamed Munir, Chung Wen-Hung, Sukasem Chonlaph |
Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs. Frontiers in pharmacology 2021 10 12 648262. Macías Yolanda, García-Menaya Jesús M, Martí Manuel, Cordobés Concepción, Jurado-Escobar Raquel, Cornejo-García José A, Torres María J, Blanca-López Natalia, Canto Gabriela, Blanca Miguel, Laguna José J, Bartra Joan, Rosado Ana, Fernández Javier, García-Martín Elena, Agúndez José A |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: